STRI PERFECTS STEM-CELL PLURIPOTENCY TO ENABLE 3D PRINTING OF HUMAN ORGANS
[South China Morning Post] April 17th, 2020
Within five years, the global stem cell market will exceed US $15 billion, prompting industry players to intensify research collaborations, and mergers and acquisitions to develop innovative solutions that could eradicate incurable diseases such as cancer or improve the life expectancy of ageing populations. In this highly competitive market, South Korea’s pioneering STC-Stem Cell Treatment & Research Institute (STRI) stands out with its breakthrough technology perfecting the pluripotency of stem cells….
You can download the original article here | Go to page 4